ZA786075B - 13,14-didehydro-protaglandins and process for their preparation - Google Patents

13,14-didehydro-protaglandins and process for their preparation

Info

Publication number
ZA786075B
ZA786075B ZA00786075A ZA786075A ZA786075B ZA 786075 B ZA786075 B ZA 786075B ZA 00786075 A ZA00786075 A ZA 00786075A ZA 786075 A ZA786075 A ZA 786075A ZA 786075 B ZA786075 B ZA 786075B
Authority
ZA
South Africa
Prior art keywords
protaglandins
didehydro
preparation
Prior art date
Application number
ZA00786075A
Other languages
English (en)
Inventor
R Ceserani
C Passarotti
C Gandolfi
F Faustini
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ZA786075B publication Critical patent/ZA786075B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
ZA00786075A 1977-11-15 1978-10-27 13,14-didehydro-protaglandins and process for their preparation ZA786075B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT29654/77A IT1088966B (it) 1977-11-15 1977-11-15 13,14-dideidro-prostaglandine

Publications (1)

Publication Number Publication Date
ZA786075B true ZA786075B (en) 1979-10-31

Family

ID=11228185

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00786075A ZA786075B (en) 1977-11-15 1978-10-27 13,14-didehydro-protaglandins and process for their preparation

Country Status (8)

Country Link
US (1) US4551476A (US07902200-20110308-C00004.png)
JP (1) JPS5484555A (US07902200-20110308-C00004.png)
BE (1) BE871957A (US07902200-20110308-C00004.png)
DE (1) DE2847049A1 (US07902200-20110308-C00004.png)
FR (1) FR2408589A1 (US07902200-20110308-C00004.png)
GB (3) GB2009145B (US07902200-20110308-C00004.png)
IT (1) IT1088966B (US07902200-20110308-C00004.png)
ZA (1) ZA786075B (US07902200-20110308-C00004.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543353A (en) * 1981-11-27 1985-09-24 Farmitalia Carlo Erba S.P.A. Ester and amide derivatives of 13,14-didehydro prostaglandins
GB2130575B (en) * 1982-11-09 1985-12-11 Erba Farmitalia Amide derivatives of 13, 14-didehydro-cycloalkyl-prostaglandins
GB8329559D0 (en) * 1983-11-04 1983-12-07 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins preparations
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
WO2006137472A1 (ja) * 2005-06-24 2006-12-28 Taisho Pharmaceutical Co., Ltd. プロスタグランジン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1053781B (it) * 1974-09-25 1981-10-10 Erba C S P A Ora Farmitalia Omega nor cicloalcil 13.14 deidro prostaglandine
IT1037126B (it) * 1975-03-14 1979-11-10 Erba Carlo Spa 13.4 deidro ii desossi prosta glandine
IL49761A0 (en) * 1975-06-27 1976-08-31 Erba Carlo Spa 16,16-dimethyl-prostaglandins and process for their preparation
FI71138C (fi) * 1976-12-31 1986-11-24 Erba Farmitalia Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner

Also Published As

Publication number Publication date
GB2086373B (en) 1982-11-24
US4551476A (en) 1985-11-05
JPS5484555A (en) 1979-07-05
IT1088966B (it) 1985-06-10
FR2408589A1 (fr) 1979-06-08
DE2847049A1 (de) 1979-05-17
GB2009145A (en) 1979-06-13
FR2408589B1 (US07902200-20110308-C00004.png) 1983-10-07
DE2847049C2 (US07902200-20110308-C00004.png) 1987-04-16
BE871957A (fr) 1979-03-01
GB2085872B (en) 1982-12-08
GB2085872A (en) 1982-05-06
GB2086373A (en) 1982-05-12
GB2009145B (en) 1982-08-11

Similar Documents

Publication Publication Date Title
DE2860060D1 (en) Process for the preparation of 2,2'-dichlorohydrazobenzene
DE2860077D1 (en) Cycloaminals, process for their preparation and their application
ZA783511B (en) Sulfamoyl-aryl-ketones and process for the preparation thereof
JPS53124297A (en) D*1*55methyltetrahydrochlorophylate and process for preparing same
IL54831A0 (en) 1-aryl-4-alkyl-1,2,4-triazol-5-ones and process for the manufacture thereof
GB2000137B (en) Process for the preparation of 7,8-dihydro-14-hydroxynormorphine
IL51877A (en) -nor-16-benzyl or phenoxy-13,14-dehydro-prostaglandins and process for their preparation
IL52424A (en) 2,7-dihydroxy-5-isopropyliden-9-alkyl-2,6-methano-3,4,5,6-tetrahydro-2h-1-benzoxocin derivatives and process for their preparation
DE2860928D1 (en) 2,4-diamino-5-benzyl-pyrimidines, process for their preparation and medicines containing them
JPS53119889A (en) 4*55disubstituted thiazoue and process for preparing same
JPS53149976A (en) 1*33oxathiolenesulfoxide and process for preparing same
IL54517A (en) 3,5-disubstituted-1h-1,2,4-triazole derivatives and process for their preparation
IL52099A (en) 5,6-dihydroprostacyclin derivatives and process for their preparation
GB1531567A (en) 13,14-dehydro-11-deoxy-prostaglandins and process for their preparation
ZA786075B (en) 13,14-didehydro-protaglandins and process for their preparation
ZA784023B (en) Substituted 2-cyclopropyl-chromones and process for their preparation
GB2007669B (en) 2,4-diamino-5-benzylpyrimidines and a process for their preparation
IL55139A0 (en) Substituted 2-cyclopropyl-chromones and process for their preparation
ZA786963B (en) 5,6-dihydro-prostacyclin derivatives and process for their preparation
GB2030977B (en) 2,1-benzisothiazoles and preparation thereof
PT67994B (en) Benzylpyrimidines and process for the preparation thereof
PT68626A (en) Process for the preparation of 2-furyl-(3,4-dimethyl-2-pyridyl)-carbinol
JPS53127499A (en) Improved process for preparing leurocine derivtatives thereof and improved process for preparing same
IL49761A0 (en) 16,16-dimethyl-prostaglandins and process for their preparation
DE2963118D1 (en) 3,3-bisfluoromethyl-butan-2-one and process for its preparation